A Review of Concurrent Chemo/Radiation, Immunotherapy, Radiation Planning, and Biomarkers for Locally Advanced Non-small Cell Lung Cancer and Their Role in the Development of ECOG-ACRIN EA5181.

MLA

Varlotto, John Michael, et al. “A Review of Concurrent Chemo/Radiation, Immunotherapy, Radiation Planning, and Biomarkers for Locally Advanced Non-Small Cell Lung Cancer and Their Role in the Development of ECOG-ACRIN EA5181.” Clinical Lung Cancer, vol. 23, no. 7, Nov. 2022, pp. 547–60. EBSCOhost, https://doi.org/10.1016/j.cllc.2022.06.005.

APA

Varlotto, J. M., Sun, Z., Ky, B., Upshaw, J., Fitzgerald, T. J., Diehn, M., Lovly, C., Belani, C., Oettel, K., Masters, G., Harkenrider, M., Ross, H., Ramalingam, S., & Pennell, N. A. (2022). A Review of Concurrent Chemo/Radiation, Immunotherapy, Radiation Planning, and Biomarkers for Locally Advanced Non-small Cell Lung Cancer and Their Role in the Development of ECOG-ACRIN EA5181. Clinical Lung Cancer, 23(7), 547–560. https://doi.org/10.1016/j.cllc.2022.06.005

Chicago

Varlotto, John Michael, Zhuoxin Sun, Bonnie Ky, Jenica Upshaw, Thomas J Fitzgerald, Max Diehn, Christine Lovly, et al. 2022. “A Review of Concurrent Chemo/Radiation, Immunotherapy, Radiation Planning, and Biomarkers for Locally Advanced Non-Small Cell Lung Cancer and Their Role in the Development of ECOG-ACRIN EA5181.” Clinical Lung Cancer 23 (7): 547–60. doi:10.1016/j.cllc.2022.06.005.